Best of the Week: August 8 – August 14, 2025

Let’s dive into the top stories shaping the conversation this week. Summaries of each article are listed below.

1. CST Celebrates National CBD Day 2025

August 8, 2025, symbolizes National CBD Day for the cannabis community. The cannabidiol-themed (CBD) holiday was founded in 2018 by cbdMD to help bring recognition to the cannabinoid.

To celebrate, Cannabis Science and Technology is putting the spotlight on CBD by compiling CBD-related content, new and old. From medical studies to science, CBD is a fascinating topic that Cannabis Science and Technology is dedicated to covering closely. Enjoy National CBD Day 2025!

2. Legislation Introduced in Pennsylvania House for Medical Cannabis Patients’ Workers’ Compensation

Legislation was recently introduced in the Pennsylvania House that would require employers, though their workers’ compensation insurers, to reimburse qualified employees for the cost of medical cannabis. The bill, House Bill 1766, would amend the act of June 2, 1915 (P.L.736, No.338), known as the Workers' Compensation Act. The proposed subparagraph to be added to Section 306 of P.L.736, No.338 states that employees who are medical cannabis patients receiving workers’ compensation and who qualify for the dollar-for-dollar reimbursement would receive a maximum of $250 per month and a yearly maximum of $3000 to cover the cost of their medical cannabis purchases.

Additionally, the employee would be eligible to have their medical cannabis card fee and renewal fee also reimbursed.

3. Trump Administration Examining Possibility of Cannabis Rescheduling

The Trump Administration is reportedly looking into the reclassification of cannabis, offering a timeline for a decision on the possible change.

“We're only looking at that,” Trump stated in a press conference on August 11. “That's early, but you know, somebody reported it, which is fine. We're looking at it. Some people like it, some people hate it. Some people hate the whole concept of marijuana because if it does bad for the children, it does bad for people that are older than children. But we're looking at reclassification and we'll make a determination over the next, I would say, over the next few weeks and that determination hopefully will be the right one.”

4. August 2025 Healer Webinar: Research on Cannabis and Sleep, Part I

In this month’s webinar, Dustin Sulak, DO, explains recent research and studies on cannabinoids for sleep, sleep apnea, and the potential effect of inflammation. Here, we present a summary of the first three out of seven studies presented in this webinar.

5. CBD Insomnia Clinical Trial Researchers Seeking to Recruit 500 Patients in Australia

Avecho Biotechnology Limited (Avecho) announced in a recent press release that the company is looking to recruit Australians for a clinical trial exploring the use of a pharmaceutical cannabidiol (CBD) product for insomnia. The placebo-controlled clinical trial will investigate Avecho’s proprietary Tocopheryl Phosphate Mixture (TPM) oral soft-gel capsules taken at night over the course of eight weeks and at doses of 75 mg and 150 mg of CBD, as well as a placebo.

In 2020, the Australian Therapeutics Goods Administration (TGA) allowed for oral CBD products to be registered in the country as over the counter (OTC) medicines, allowing for easier access for consumers.